11654

539524

LALPATHLAB

img img img img
No Data Available

DR. LAL PATH LABS LTD. Share Price Update

As of the latest trading session, DR. LAL PATH LABS LTD. is trading at ₹1607.4, down by ₹-9.79 or -0.60% from its previous close. The stock has moved between ₹1585.90 and ₹1638.10 today. Over the past year, the stock has delivered a return of 13.62%. In the last month, it has returned 14.99%.

DR. LAL PATH LABS LTD. performance

Today’s low Today’s high
₹ 1585.90 ₹ 1638.10
₹ 1607.40
52 week low 52 week high
₹ 1272.60 ₹ 1770.00
₹ 1607.40
Open Price ₹ 1617.00
Prev. Close ₹ 1617.20
Volume (Shares) 414912.00
Total traded value ₹ 6669.29
Upper Circuit ₹ 1940.60
Lower Circuit ₹ 1293.80
info

Investment Returns

Over 1 Month 14.99% Over 3 Months 14.33% Over 6 Months 5.33% Over 1 Year 13.62%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

DR. LAL PATH LABS LTD. fundamentals


  • Market cap (Cr) 26,946.10
  • P/E Ratio (TTM) 52.76
  • Beta 0.46
  • Book Value / share 147.51
  • Return on equity 25.27%
  • EPS (TTM) 31.70
  • Dividend yield 1.53%
  • Net profit/quarter (Cr) 141.10
info icon alternate text
  • Market cap (Cr) 26,817.90
  • P/E Ratio (TTM) 52.76
  • Beta 0.41
  • Book Value / share 147.51
  • Return on equity 25.27%
  • EPS (TTM) 31.70
  • Dividend yield 1.53%
  • Net profit/quarter (Cr) 141.10
info icon alternate text

DR. LAL PATH LABS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 675.20
Operating Expense 542.30
Net Profit 141.10
Net Profit Margin (%) 20.89
Earnings Per Share (EPS) 8.45
EBITDA 218.50
Effective Tax Rate (%) 16.95
Particulars DEC 2025 (Values in Cr)
Revenue 632.10
Operating Expense 505.50
Net Profit 92.10
Net Profit Margin (%) 14.57
Earnings Per Share (EPS) 5.52
EBITDA 170.20
Effective Tax Rate (%) 25.18
Particulars SEP 2025 (Values in Cr)
Revenue 699.60
Operating Expense 527.60
Net Profit 145.70
Net Profit Margin (%) 20.82
Earnings Per Share (EPS) 17.46
EBITDA 237.90
Effective Tax Rate (%) 25.20
Particulars JUN 2025 (Values in Cr)
Revenue 640.70
Operating Expense 494.60
Net Profit 129.30
Net Profit Margin (%) 20.18
Earnings Per Share (EPS) 15.51
EBITDA 209.70
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Revenue 577.20
Operating Expense 457.50
Net Profit 148.40
Net Profit Margin (%) 25.71
Earnings Per Share (EPS) 17.80
EBITDA 184.30
Effective Tax Rate (%) -2.41
Particulars MAR 2026 (Values in Cr)
Revenue 2647.60
Operating Expense 2070.00
Net Profit 508.20
Net Profit Margin (%) 19.19
Earnings Per Share (EPS) 30.45
EBITDA 836.30
Effective Tax Rate (%) 23.02
Particulars MAR 2025 (Values in Cr)
Revenue 2351.60
Operating Expense 1841.80
Net Profit 497.30
Net Profit Margin (%) 21.14
Earnings Per Share (EPS) 59.70
EBITDA 777.00
Effective Tax Rate (%) 19.95
Particulars MAR 2024 (Values in Cr)
Revenue 2125.10
Operating Expense 1708.89
Net Profit 346.70
Net Profit Margin (%) 16.31
Earnings Per Share (EPS) 41.72
EBITDA 646.90
Effective Tax Rate (%) 28.14
Particulars MAR 2023 (Values in Cr)
Revenue 1769.00
Operating Expense 1424.80
Net Profit 292.40
Net Profit Margin (%) 16.52
Earnings Per Share (EPS) 35.28
EBITDA 507.29
Effective Tax Rate (%) 25.17
Particulars MAR 2022 (Values in Cr)
Revenue 1878.80
Operating Expense 1470.89
Net Profit 345.30
Net Profit Margin (%) 18.37
Earnings Per Share (EPS) 41.61
EBITDA 565.50
Effective Tax Rate (%) 25.09
Particulars MAR 2025 (Values in Cr)
Book Value / Share 259.92
ROE % 24.48
ROCE % 29.22
Total Debt to Total Equity 0.10
EBITDA Margin 32.06
Particulars MAR 2024 (Values in Cr)
Book Value / Share 221.53
ROE % 20.61
ROCE % 25.57
Total Debt to Total Equity 0.19
EBITDA Margin 30.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 199.87
ROE % 15.22
ROCE % 18.51
Total Debt to Total Equity 0.30
EBITDA Margin 26.36
Particulars MAR 2022 (Values in Cr)
Book Value / Share 180.17
ROE % 25.51
ROCE % 29.46
Total Debt to Total Equity 0.25
EBITDA Margin 29.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 149.39
ROE % 26.03
ROCE % 32.56
Total Debt to Total Equity 0.07
EBITDA Margin 30.84
Particulars MAR 2025 (Values in Cr)
Book Value / Share 255.32
ROE % 25.27
ROCE % 29.72
Total Debt to Total Equity 0.05
EBITDA Margin 33.04
Particulars MAR 2024 (Values in Cr)
Book Value / Share 215.71
ROE % 19.87
ROCE % 24.77
Total Debt to Total Equity 0.12
EBITDA Margin 30.44
Particulars MAR 2023 (Values in Cr)
Book Value / Share 202.70
ROE % 18.49
ROCE % 20.93
Total Debt to Total Equity 0.21
EBITDA Margin 28.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 176.63
ROE % 25.68
ROCE % 29.69
Total Debt to Total Equity 0.14
EBITDA Margin 30.10
Particulars MAR 2021 (Values in Cr)
Book Value / Share 148.43
ROE % 25.08
ROCE % 32.04
Total Debt to Total Equity 0.00
EBITDA Margin 30.77
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 838.67
Total Assets 2716.78
Total Liabilities 2716.78
Total Equity 2206.47
Share Outstanding 8
Price to Book Ratio 9.71
Return on Assets (%) 17.93
Return on Capital (%) 22.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 830.31
Total Assets 2455.96
Total Liabilities 2455.96
Total Equity 1885.36
Share Outstanding 8
Price to Book Ratio 10.49
Return on Assets (%) 14.56
Return on Capital (%) 18.17
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 665.41
Total Assets 2385.56
Total Liabilities 2385.56
Total Equity 1699.54
Share Outstanding 8
Price to Book Ratio 9.02
Return on Assets (%) 10.01
Return on Capital (%) 12.34
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 617.59
Total Assets 2353.22
Total Liabilities 2353.22
Total Equity 1543.53
Share Outstanding 8
Price to Book Ratio 14.76
Return on Assets (%) 14.65
Return on Capital (%) 18.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 926.02
Total Assets 1661.33
Total Liabilities 1661.33
Total Equity 1276.01
Share Outstanding 8
Price to Book Ratio 18.24
Return on Assets (%) 17.55
Return on Capital (%) 22.85
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 767.53
Total Assets 2620.95
Total Liabilities 2620.95
Total Equity 2134.23
Share Outstanding 8
Price to Book Ratio 9.71
Return on Assets (%) 18.97
Return on Capital (%) 23.3
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 751.67
Total Assets 2349.16
Total Liabilities 2349.16
Total Equity 1800.72
Share Outstanding 8
Price to Book Ratio 10.49
Return on Assets (%) 14.75
Return on Capital (%) 18.4
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 534.21
Total Assets 2320.17
Total Liabilities 2320.17
Total Equity 1689.86
Share Outstanding 8
Price to Book Ratio 9.02
Return on Assets (%) 12.60
Return on Capital (%) 15.18
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 542.90
Total Assets 2210.78
Total Liabilities 2210.78
Total Equity 1472.11
Share Outstanding 8
Price to Book Ratio 14.76
Return on Assets (%) 15.61
Return on Capital (%) 19
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 888.63
Total Assets 1573.07
Total Liabilities 1573.07
Total Equity 1217.08
Share Outstanding 8
Price to Book Ratio 18.24
Return on Assets (%) 17.80
Return on Capital (%) 23.01
Particulars MAR 2025 (Values in Cr)
Net Income 492.25
Cash from Operations 732.78
Cash from Investing -303.16
Cash from Financing -334.02
Net change in Cash -68.30
Free Cash Flow 777.07
Particulars MAR 2024 (Values in Cr)
Net Income 362.29
Cash from Operations 667.36
Cash from Investing -24.26
Cash from Financing -413.86
Net change in Cash 97.20
Free Cash Flow 718.53
Particulars MAR 2023 (Values in Cr)
Net Income 241.07
Cash from Operations 562.46
Cash from Investing -287.30
Cash from Financing -283.18
Net change in Cash -114.46
Free Cash Flow 598.97
Particulars MAR 2022 (Values in Cr)
Net Income 350.29
Cash from Operations 576.72
Cash from Investing -449.24
Cash from Financing 136.45
Net change in Cash 133.89
Free Cash Flow 670.82
Particulars MAR 2021 (Values in Cr)
Net Income 296.47
Cash from Operations 499.85
Cash from Investing -212.01
Cash from Financing -138.55
Net change in Cash 47.57
Free Cash Flow 535.41
Particulars MAR 2025 (Values in Cr)
Net Income 497.26
Cash from Operations 694.63
Cash from Investing -292.99
Cash from Financing -324.74
Net change in Cash -77.74
Free Cash Flow 737.94
Particulars MAR 2024 (Values in Cr)
Net Income 346.73
Cash from Operations 632.42
Cash from Investing 1.16
Cash from Financing -410.53
Net change in Cash 95.23
Free Cash Flow 679.51
Particulars MAR 2023 (Values in Cr)
Net Income 292.35
Cash from Operations 526.65
Cash from Investing -288.47
Cash from Financing -270.04
Net change in Cash -130.98
Free Cash Flow 558.36
Particulars MAR 2022 (Values in Cr)
Net Income 345.25
Cash from Operations 543.25
Cash from Investing -448.53
Cash from Financing 141.24
Net change in Cash 118.43
Free Cash Flow 606.34
Particulars MAR 2021 (Values in Cr)
Net Income 280.10
Cash from Operations 470.47
Cash from Investing -195.19
Cash from Financing -135.74
Net change in Cash 42.42
Free Cash Flow 498.52
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8177.95 60.11 12.41 117586.37 6680.00 8490.30
FORTIS MALAR HOSPITALS LIMITED 53.98 24.43 2.94 101.17 40.75 77.00
SHREE PACETRONIX LTD. 142.40 16.99 2.99 53.40 66.10 283.15
TRANSGENE BIOTEK LTD. 3.15 0.00 2.59 23.87 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8177.95 78.33 11.80 117586.37 6680.00 8490.30
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.69 0.00 -9.41 28.90 30.30 57.48
KOVAI MEDICAL CENTER & HO 5357.25 23.97 4.44 5860.83 5010.00 6725.00

DR. LAL PATH LABS LTD. shareholding pattern

Holding
8.22%
53.21%
17.18%
21.38%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

DR. LAL PATH LABS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1607.40 -0.60 redarrow
red-green-graph indicator
6 Bearish
10 Bullish
  • 5 Days 1618.50
  • 26 Days 1569.00
  • 10 Days 1619.10
  • 50 Days 1513.90
  • 12 Days 1615.00
  • 100 Days 1479.40
  • 20 Days 1589.00
  • 200 Days 1476.60
1615.33 PIVOT
First Support 1593.87 First Resistance 1638.67 Second Support 1570.53 Second Resistance 1660.13 Third Support 1549.07 Third Resistance 1683.47
RSI 55.66 ADX 45.34 MACD 45.99 Williams % R -74.06 Commodity Channel Index (CCI) 11.00
Date 2026-05-29 Week 161477.00 Same Day 271187.00 Month 278141.00
1 Year 0.47 3 Year 0.50
Over 1 Month
14.99% down
Over 1 Year
13.62% down
Over 3 Months
14.33% down
Over 3 Years
16.26% down
Over 6 Months
5.33% down
Over 5 Years
1.69% down

DR. LAL PATH LABS LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
25 Jun 2026 4.0 Final 26 Jun 2026 Equity shares
05 Feb 2026 3.5 Interim 3 05 Feb 2026 Equity shares
07 Nov 2025 7.0 Interim 2 07 Nov 2025 Equity shares
06 Aug 2025 6.0 Interim 06 Aug 2025 Equity shares
06 Jun 2025 6.0 Final 06 Jun 2025 Equity shares
05 Feb 2025 6.0 Interim 3 05 Feb 2025 Equity shares
05 Nov 2024 6.0 Interim 2 05 Nov 2024 Equity shares
20 Aug 2024 6.0 Interim 20 Aug 2024 Equity shares
10 Jun 2024 6.0 Final 10 Jun 2024 Equity shares
13 Feb 2024 12.0 Interim 2 13 Feb 2024 Equity shares
11 Aug 2023 6.0 Interim 11 Aug 2023 Equity shares
11 Aug 2023 6.0 Final 11 Aug 2023 Equity shares
05 Aug 2022 6.0 Interim 09 Aug 2022 Equity shares
22 Jun 2022 6.0 Final 23 Jun 2022 Equity shares
18 Aug 2021 6.0 Interim 22 Aug 2021 Equity shares
20 Jul 2021 8.0 Final 22 Jul 2021 Equity shares
09 Feb 2021 6.0 Interim 2 10 Feb 2021 Equity shares
18 Nov 2020 6.0 Interim 19 Nov 2020 Equity shares
05 Mar 2020 6.0 Interim 2 06 Mar 2020 Equity shares
20 Nov 2019 6.0 Interim 21 Nov 2019 Equity shares
02 Aug 2019 3.5 Final 06 Aug 2019 Equity shares
19 Nov 2018 2.5 Interim 20 Nov 2018 Equity shares
03 Aug 2018 3.0 Final 07 Aug 2018 Equity shares
20 Nov 2017 1.5 Interim 21 Nov 2017 Equity shares
12 Jul 2017 1.7 Final 14 Jul 2017 Equity shares
13 Feb 2017 1.3 Interim 14 Feb 2017 Equity shares
20 Jul 2016 2.45 Final 22 Jul 2016 Equity shares
Ex-Date Ex-Bonus Ratio
19 Dec 2025 19 Dec 2025 1:1
Dividend date Dividend amount Dividend type Record date Instrument type
25 Jun 2026 4.0 Final 26 Jun 2026 Equity shares
05 Feb 2026 3.5 Interim 3 05 Feb 2026 Equity shares
07 Nov 2025 7.0 Interim 2 07 Nov 2025 Equity shares
06 Aug 2025 6.0 Interim 06 Aug 2025 Equity shares
06 Jun 2025 6.0 Final 06 Jun 2025 Equity shares
05 Feb 2025 6.0 Interim 3 05 Feb 2025 Equity shares
05 Nov 2024 6.0 Interim 2 05 Nov 2024 Equity shares
20 Aug 2024 6.0 Interim 20 Aug 2024 Equity shares
10 Jun 2024 6.0 Final 10 Jun 2024 Equity shares
13 Feb 2024 12.0 Interim 2 13 Feb 2024 Equity shares
11 Aug 2023 6.0 Interim 11 Aug 2023 Equity shares
11 Aug 2023 6.0 Final 11 Aug 2023 Equity shares
05 Aug 2022 6.0 Interim 09 Aug 2022 Equity shares
22 Jun 2022 6.0 Final 23 Jun 2022 Equity shares
18 Aug 2021 6.0 Interim 22 Aug 2021 Equity shares
20 Jul 2021 8.0 Final 22 Jul 2021 Equity shares
09 Feb 2021 6.0 Interim 2 10 Feb 2021 Equity shares
18 Nov 2020 6.0 Interim 19 Nov 2020 Equity shares
05 Mar 2020 6.0 Interim 2 06 Mar 2020 Equity shares
20 Nov 2019 6.0 Interim 21 Nov 2019 Equity shares
02 Aug 2019 3.5 Final 06 Aug 2019 Equity shares
19 Nov 2018 2.5 Interim 20 Nov 2018 Equity shares
03 Aug 2018 3.0 Final 07 Aug 2018 Equity shares
20 Nov 2017 1.5 Interim 21 Nov 2017 Equity shares
12 Jul 2017 1.7 Final 14 Jul 2017 Equity shares
13 Feb 2017 1.3 Interim 14 Feb 2017 Equity shares
20 Jul 2016 2.45 Final 22 Jul 2016 Equity shares
Ex-Date Ex-Bonus Ratio
19 Dec 2025 19 Dec 2025 1:1

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Dr Lal Pathlabs Ltd?

Answer Field

Dr Lal Pathlabs Ltd share price is for NSE ₹ 1,607.40 & for BSE ₹ 1,607.20 as on May 29 2026 03:30 PM.

What is the Market Cap of Dr Lal Pathlabs Ltd Share?

Answer Field

The market cap of Dr Lal Pathlabs Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 29 2026 03:30 PM.

What is the 52 Week High and Low of Dr Lal Pathlabs Ltd?

Answer Field

The 52 Week High and Low of Dr Lal Pathlabs Ltd for NSE is ₹ 1,770.00 and ₹ 1,272.60 and for BSE is ₹ 1,771.30 and ₹ 1,272.00.

What is 1 year return for Dr Lal Pathlabs Ltd?

Answer Field

The 1 year returns on the stock has been 13.62%.

What is the P/E Ratio of Dr Lal Pathlabs Ltd Share?

Answer Field

As on May 29 2026 03:30 PM the price-to-earnings (PE) ratio for Dr Lal Pathlabs Ltd share is 52.76.

What is the PB ratio of Dr Lal Pathlabs Ltd Share?

Answer Field

As on May 29 2026 03:30 PM, the price-to-book (PB) ratio for Dr Lal Pathlabs Ltd share is 147.51.

How to Buy Dr Lal Pathlabs Ltd Share?

Answer Field

You can trade in Dr Lal Pathlabs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Dr Lal Pathlabs Ltd Share on Bajaj Broking App?

Answer Field

To buy Dr Lal Pathlabs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Dr Lal Pathlabs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|